Carl Zeiss Meditec
€31.30Change from previous close: +0.32%Absolute change: +€0.10
At a glance
- Revenue growth
- +7.82%
- FY to Sep 2025 vs FY to Sep 2024
- Net income growth
- −20.99%
- FY to Sep 2025 vs FY to Sep 2024
- Net margin
- 6.3%
- FY to Sep 2024: 8.7%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | FY to Sep 2025 | FY to Sep 2024 | FY to Sep 2023 | FY to Sep 2022 |
|---|---|---|---|---|
| Total revenue | 2,228 | 2,066 | 2,089 | 1,903 |
| Cost of revenue | 1,052 | 977 | 884 | 775 |
| Gross profit | 1,175 | 1,089 | 1,206 | 1,128 |
| Selling, general and administrative | 627 | 569 | 504 | 438 |
| Research and development | 326 | 343 | 349 | 291 |
| Operating income | 223 | 194 | 348 | 397 |
| EBIT | 221 | 270 | 428 | 413 |
| EBITDA | 347 | 403 | 502 | 483 |
| Interest expense | 26.6 | 29.4 | 15.3 | 9.6 |
| Pre-tax income | 194 | 241 | 413 | 403 |
| Income tax | 51.5 | 60.7 | 121 | 108 |
| Net income | 141 | 179 | 290 | 294 |
| Net income to common shareholders | 141 | 179 | 290 | 294 |
| Basic EPS | 1.61 | 2.01 | 3.25 | 3.29 |
| Diluted EPS | 1.61 | 2.01 | 3.25 | 3.29 |
| Average shares (basic) | 87.5 | 88.9 | 89.4 | 89.4 |
| Average shares (diluted) | 87.5 | 88.9 | 89.4 | 89.4 |